Human mast cell migration in response to members of the transforming growth factor-beta family - PubMed (original) (raw)
Human mast cell migration in response to members of the transforming growth factor-beta family
N Olsson et al. J Leukoc Biol. 2000 Mar.
Abstract
Mast cells are known to accumulate at sites of inflammation, however, the chemotaxins involved remain largely undefined. Transforming growth factor-beta (TGF-beta) isoforms regulate numerous cellular functions, including cell growth and differentiation, formation of extracellular matrix, and the immune response. In this study we have compared the potency of different members of the TGF-beta family as human mast cell chemotaxins, and analyzed the expression of TGF-beta binding proteins on human mast cells. We were able to demonstrate that the maximal chemotactic response was attained at approximately 40 fM for the three TGF-beta isoforms, with TGF-beta3 being more effective than TGF-beta1 and TGF-beta2 at this concentration. This effect was observed in both the HMC-1 human mast cell line and in cultured primary mast cells. In addition, TGF-beta1, TGF-beta2, and less efficiently, TGF-beta3 inhibited the proliferation of HMC-1 cells. The migratory response is probably mediated through interaction with the TGF-beta serine/threonine type I and II receptors that were found to be expressed on the cells. No expression of TGF-beta type III receptor, endoglin, or the endothelial TGF-beta type I receptor ALK-1 could be detected. These results provide evidence that TGF-beta isoforms are highly potent chemotaxins for human mast cells and can play an important role in the recruitment of mast cells in inflammatory reactions.
Similar articles
- Transforming growth factor-beta 1 mediates mast cell chemotaxis.
Gruber BL, Marchese MJ, Kew RR. Gruber BL, et al. J Immunol. 1994 Jun 15;152(12):5860-7. J Immunol. 1994. PMID: 7515916 - Regulation of proliferation and migration in retinoic acid treated C3H10T1/2 cells by TGF-beta isoforms.
Makhijani NS, Bischoff DS, Yamaguchi DT. Makhijani NS, et al. J Cell Physiol. 2005 Jan;202(1):304-13. doi: 10.1002/jcp.20128. J Cell Physiol. 2005. PMID: 15389595 - Transforming growth factor-beta-mediated mast cell migration depends on mitogen-activated protein kinase activity.
Olsson N, Piek E, Sundström M, ten Dijke P, Nilsson G. Olsson N, et al. Cell Signal. 2001 Jul;13(7):483-90. doi: 10.1016/s0898-6568(01)00176-0. Cell Signal. 2001. PMID: 11516623 - Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart.
Mercado-Pimentel ME, Runyan RB. Mercado-Pimentel ME, et al. Cells Tissues Organs. 2007;185(1-3):146-56. doi: 10.1159/000101315. Cells Tissues Organs. 2007. PMID: 17587820 Review. - TGF-betas and TGF-beta receptors in atherosclerosis.
McCaffrey TA. McCaffrey TA. Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):103-14. doi: 10.1016/s1359-6101(99)00034-9. Cytokine Growth Factor Rev. 2000. PMID: 10708958 Review.
Cited by
- TGF-beta 1 inhibits mast cell Fc epsilon RI expression.
Gomez G, Ramirez CD, Rivera J, Patel M, Norozian F, Wright HV, Kashyap MV, Barnstein BO, Fischer-Stenger K, Schwartz LB, Kepley CL, Ryan JJ. Gomez G, et al. J Immunol. 2005 May 15;174(10):5987-93. doi: 10.4049/jimmunol.174.10.5987. J Immunol. 2005. PMID: 15879091 Free PMC article. - ADAM10 is required for SCF-induced mast cell migration.
Faber TW, Pullen NA, Fernando JF, Kolawole EM, McLeod JJ, Taruselli M, Williams KL, Rivera KO, Barnstein BO, Conrad DH, Ryan JJ. Faber TW, et al. Cell Immunol. 2014 Jul;290(1):80-8. doi: 10.1016/j.cellimm.2014.05.005. Epub 2014 May 21. Cell Immunol. 2014. PMID: 24950026 Free PMC article. - Comparison of temporal transcriptomic profiles from immature lungs of two rat strains reveals a viral response signature associated with chronic lung dysfunction.
Hines EA, Szakaly RJ, Leng N, Webster AT, Verheyden JM, Lashua AJ, Kendziorski C, Rosenthal LA, Gern JE, Sorkness RL, Sun X, Lemanske RF Jr. Hines EA, et al. PLoS One. 2014 Dec 1;9(12):e112997. doi: 10.1371/journal.pone.0112997. eCollection 2014. PLoS One. 2014. PMID: 25437859 Free PMC article. - Phosphorylated ERK is a potential prognostic biomarker for Sorafenib response in hepatocellular carcinoma.
Liang Y, Chen J, Yu Q, Ji T, Zhang B, Xu J, Dai Y, Xie Y, Lin H, Liang X, Cai X. Liang Y, et al. Cancer Med. 2017 Dec;6(12):2787-2795. doi: 10.1002/cam4.1228. Epub 2017 Oct 13. Cancer Med. 2017. PMID: 29030911 Free PMC article. - Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients.
Olsson N, Ulfgren AK, Nilsson G. Olsson N, et al. Ann Rheum Dis. 2001 Mar;60(3):187-93. doi: 10.1136/ard.60.3.187. Ann Rheum Dis. 2001. PMID: 11171676 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources